Abstract
Background Sitosterolemia is a rare inherited disorder caused by mutations in the ABCG5/ABCG8 genes. These genes encode proteins that are involved in the transport of plant sterols (phytosterols) out of the body. Mutations in these genes lead to decreased excretion of phytosterols, which can accumulate in the body and lead to a variety of health problems, including xanthoma formation, atherosclerosis, and premature coronary artery disease.
Methods We conducted the first genome-wide association study (GWAS) in the Middle East/North Africa (MENA) population to identify genetic determinants of plant sterol levels in Qatari people. GWAS was performed on serum levels of β-sitosterol and campesterol measured using the Metabolon platform from the Qatar Biobank Cohort and genome sequence data provided by Qatar Genome Program. Furthermore, a trans-ancestry meta-analysis of data from our Qatari cohort with summary statistics from a previously published large cohort (9,758 subjects) of European ancestry was conducted.
Results Using conditional analysis, we identified two independent single nucleotide polymorphisms (SNPs) associated with β-sitosterol (rs145164937 and rs4299376), and two independent SNPs associated with campesterol (rs7598542 and rs75901165) in the Qatari population in addition to two previously reported variants (rs199689137 and rs4245791). All of them map to the ABCG5/8 locus except rs75901165 which is located within the Intraflagellar Transport 43 (IFT43) gene. The meta-analysis replicated most of the reported variants, and our study provided significant support for the association of variants in SCARB1 and ABO with sitosterolemia.
Conclusions This is the first study to shed light on genetic determinants of phytosterols in the MENA region using a genome-wide association approach. We also established the first polygenic risk score for this trait using the European large cohort study. These findings may have future implications on the personalized treatment of hyperlipidemia in general while showing the importance of building population-specific multi-omics databases.
The formulation of the first polygenic risk score for sitosterolemia provides an exceptionally reliable tool for polygenic evaluation.
Plant sterol measurement should be included in lipid panel checkups and genetic screening for patients with tendon xanthomas to ensure an accurate diagnosis.
The establishment of regional and national registries for sitosterolemia in the Qatari community is essential for effective monitoring of the incidence of the disease and reducing the risk of early coronary artery disease.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
No clinical trial.
Funding Statement
No external funding was recieved.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the QBB Institutional Review Board (IRB) under Protocol no. E2021-QF-QBB-RES-ACC-00016-0158.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in this study are subject to certain licenses and restrictions. The raw whole-genome sequence data from Qatar Biobank cannot be deposited into public databases due to data privacy laws. However, access to the QBB/QGP phenotype and whole-genome sequence data can be obtained through an ISO-certified protocol. This involves submitting a project request at https://www.qatarbiobank.org.qa/research/how-apply, which must be approved by the Institutional Review Board of the QBB. If you wish to access these datasets, please visit https://www.qatarbiobank.org.qa/research/how-apply for more information.
